Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1.

Journal of immunology (Baltimore, Md. : 1950) - 15 Jan 1994

Nickells M W, Alvarez J I, Lublin D M, Atkinson J P

Abstract excerpt

Human E express two surface forms of decay-accelerating factor (DAF; CD55). On SDS-PAGE under reducing conditions the major form, DAF-1, migrates as a 70-kDa protein and the minor form, DAF-2, present at < 10% the amount of DAF-1, migrates as a 140-kDa protein (Kinoshita, T., S. I. Rosenfeld, and V. Nussenzweig. 1987. J. Immunol. 138:2994). Both forms possess decay-accelerating activity and, after purification...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Sequence
Share to Base Sequence

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA Primers

Share to Gene Expression

Share to Molecular Sequence Data

Share to Mutation

Share to RNA, Messenger

Source

Identifiers

PMID: 7506731

Genes

SDS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1.PMID 7506731Read ↗

Conservation in decay accelerating factor (DAF) structure among primates.Semantic proximity Read ↗

Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants.Semantic proximity Read ↗

Interactions of decay-accelerating factor (DAF) with haemagglutinating human enteroviruses: utilizing variation in primate DAF to map virus binding sites.Semantic proximity Read ↗

Bulk production and functional analyses of mouse CD55's native and deglycosylated active domains.Semantic proximity Read ↗

Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes.Semantic proximity Read ↗

Various forms of DAF (CD55) and C1 esterase inhibitor.Semantic proximity Read ↗

Decay-accelerating factor (CD55) deficiency phenotypes in Japanese.Semantic proximity Read ↗

Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology.Semantic proximity Read ↗

Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97Semantic proximity Read ↗

Molecular cloning and characterization of Dr-II, a nonfimbrial adhesin-I-like adhesin isolated from gestational pyelonephritis-associated Escherichia coli that binds to decay-accelerating factorSemantic proximity Read ↗

Characterization of the active sites in decay-accelerating factor.Semantic proximity Read ↗

Structural characterization of mouse CD97 and study of its specific interaction with the murine decay‐accelerating factor (DAF, CD55)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.